B&D White Capital Company’s Bristol-Myers Squibb BMY Stock Holding History

B&D White Capital Company’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-4,730	Closed	-$243K	–	61
2023 Q4	$243K	Sell	4,730 -98,400	-95%	-$5.17M	0.08%	51
2023 Q3	$5.99M	Buy	103,130 +4,755	+5%	+$291K	2.23%	12
2023 Q2	$6.29M	Buy	+98,375	New	+$6.6M	2.17%	12
2021 Q1	–	Sell	-200	Closed	-$12K	–	49
2020 Q4	$12K	Buy	+200	New	+$12.3K	0.01%	63

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

B&D White Capital Company's BMY Position: Q1 2024 in Review

B&D White Capital Company sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 4,730 shares — an estimated $243K sold.

B&D White Capital Company first reported a position in BMY in Q4 2020 and held it in 4 quarters. The position peaked at $6.29M in Q2 2023. 2,332 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

B&D White Capital Company reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
B&D White Capital Company sold 4,730 Bristol-Myers Squibb shares in Q1 2024, an estimated $243K.
B&D White Capital Company first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 4 quarters.
B&D White Capital Company's Bristol-Myers Squibb position peaked at $6.29M in Q2 2023.
2,332 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on B&D White Capital Company's 13F filing for Q1 2024, filed 10 May 2024.